Skip to content

DELCOPHARMA

Active Risk: not assessed
Private limited companyfounded 2025incorporated this yearRozenlaan 6, 1730 Asse, BelgiumKBO/BCE: BE 1031.770.885
Summary

DELCOPHARMA is younger than twelve months; there is no public track record yet to compute a bankruptcy probability from. The company has been active since 2025 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
No accounts filed yet
Financial health
No score: no figuresToo young for a probability
Structure
  • IMMO DELCOURTDirector · permanent representative DELCOURT Johan
  • DELCOURTPHARMADirector
Signals- Young companyShow the evidence

Signals

1 signal.
+raises risk
raises risk · Young company
Founded in 2025, under 3 years in business. Failure risk is statistically highest between 2 and 8 years after founding.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 0 years 0 10 y
Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
Checked from 2021 on.
KBO publications · our coverage
  1. IncorporationAppointment: DELCOURTPHARMA (niet statutair bezoldigd…

Key points

  • Founded 9 months agofounded 17-12-2025 9 months View
  • No annual accounts yetat the National Bank 0 View
  • Board2 directors in office 2 View

By topic

Company details

Sites
1
Legal form
Private limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
17-12-2025
Peppol
Reachable for e-invoices
Go to Company details

Articles of association

Provisions read
20
Who signs
Each director alone
Financial year
From 1 January to 31 December
Purpose
Het voeren van alle activiteiten die normaal behoren tot deze van de uitbating van een…
Go to Articles of association

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.